文献速递瓣膜外科

功能性三尖瓣反流三尖瓣手术结局

Outcomes of tricuspid valve surgery in patients with functional tricuspid regurgitation.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

该回顾性研究分析了1993年至2018年926例因功能性三尖瓣反流接受初次三尖瓣手术的成人患者,其中83%行三尖瓣修复,17%行三尖瓣置换。结果显示三尖瓣修复的早期死亡率、肾功能衰竭发生率和住院时间均低于置换,且远期生存更优;三尖瓣置换是远期死亡的独立危险因素。

要点

  • 功能性三尖瓣反流行三尖瓣修复的早期和远期结局优于置换。
  • 三尖瓣置换是远期死亡的独立危险因素(HR 1.36)。
  • 在二尖瓣手术时同期考虑三尖瓣修复可能获益。

核心结论

  • 功能性三尖瓣反流患者行三尖瓣修复的早期和远期结局优于三尖瓣置换。
  • 三尖瓣置换、既往二尖瓣手术、充血性心力衰竭和肾功能衰竭是远期死亡的独立危险因素。

研究设计与样本

  • 回顾性分析1993年1月至2018年6月单中心成人(≥18岁)因功能性三尖瓣反流行初次三尖瓣手术的患者926例。
  • 平均年龄68.6±12.5岁,女性占67%;767例(83%)行三尖瓣修复(瓣环成形67%,荷包缝合成形33%),159例(17%)行三尖瓣置换(生物瓣87%,机械瓣13%)。
  • 中位随访8.2年(95%CI 7.2-8.9年)。

主要发现

  • 三尖瓣置换组中重度右心室功能障碍、重度三尖瓣反流和充血性心力衰竭的比例更高(P分别<0.001、<0.001、=0.001)。
  • 三尖瓣修复组中重度二尖瓣反流和同期心脏手术的比例更高(P<0.001)。
  • 三尖瓣置换组早期死亡率9% vs 修复组3%(P=0.004),肾功能衰竭10% vs 5%(P=0.014),住院时间15±15天 vs 12±11天(P<0.001)。
  • 三尖瓣置换组生存更差(HR 1.57;95%CI 1.23-1.99)。
  • 多变量分析显示充血性心力衰竭(HR 1.37;95%CI 1.10-1.72)、肾功能衰竭(HR 1.79;95%CI 1.14-2.82)、既往二尖瓣手术(HR 1.35;95%CI 1.05-1.72)和三尖瓣置换(HR 1.36;95%CI 1.03-1.79)是远期死亡的独立危险因素。

临床怎么用

  • 对功能性三尖瓣反流患者,优先考虑三尖瓣修复而非置换。
  • 在二尖瓣手术时同期考虑三尖瓣修复,可能改善远期结局。
  • 早期转诊、在进展为晚期心力衰竭前干预可能改善结局。

局限性

  • 回顾性单中心研究,存在选择偏倚。
  • 三尖瓣置换组基线病情更重,可能影响结局比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Functional tricuspid regurgitation (fTR) has been amenable to tricuspid valve repair (TVr), with fewer patients needing tricuspid valve replacement (TVR). We sought to review our experience of tricuspid valve surgery for fTR. METHODS: A retrospective analysis of adult patients (≥18 years) who underwent primary tricuspid valve surgery for fTR (n = 926; mean age 68.6 ± 12.5 years; 67% females) from January 1993 through June 2018 was conducted. There were 767 (83%) patients who underwent TVr (ring annuloplasty, 67%; purse-string annuloplasty, 33%) and 159 (17%) underwent TVR (bioprosthetic valves, 87%; mechanical valves, 13%). The median follow-up was 8.2 years [95% confidence interval (CI) 7.2-8.9 years]. RESULTS: A greater proportion of patients who underwent TVR had severe right ventricular dysfunction (P < 0.001), severe tricuspid regurgitation (P < 0.001) and congestive heart failure (P = 0.001) while the TVr cohort had a greater proportion with severe mitral valve (MV) regurgitation (P < 0.001) and concomitant cardiac procedures. Early mortality (TVR, 9% vs TVr, 3%; P = 0.004), renal failure (TVR, 10% vs TVr, 5%; P = 0.014) and hospital stay (TVR, 15 ± 15 days vs TVr, 12 ± 11 days; P < 0.001) were greater in TVR patients. The TVR cohort had worse survival [hazard ratio (HR) 1.57; 95% CI 1.23-1.99]. Multivariable analysis identified congestive heart failure (HR 1.37; 95% CI 1.10-1.72), renal failure (HR 1.79; 95% CI 1.14-2.82), previous MV surgery (HR 1.35; 95% CI 1.05-1.72) and TVR (HR 1.36; 95% CI 1.03-1.79) as independent risk factors for late mortality. CONCLUSIONS: Tricuspid repair for fTR appears to have better early and late outcomes. Since previous MV surgery and TVR are identified as independent risk factors for late mortality, concomitant TVr at the time of index MV surgery may be considered. Early referral before the onset of advanced heart failure may improve outcomes.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Pahwa S, Saran N, Pochettino A, et al. Outcomes of tricuspid valve surgery in patients with functional tricuspid regurgitation. Eur J Cardiothorac Surg. 2021. PMID: 33159792. doi:10.1093/ejcts/ezaa350

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。